Q1 2016 Holdings
Filed 2016-05-02 | 11 holdings | $144.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Juno Therapeutics | Common Stock | 48205A109 | $46.8K | 1,229,512 | 32.5% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $32.4K | 2,138,872 | 22.5% |
| Egalet | Common Stock | 28226B104 | $19.3K | 2,814,928 | 13.4% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $17.5K | 822,175 | 12.1% |
| Nabriva Therapeutics | Sponsored ADR | 62957M104 | $10.3K | 1,145,890 | 7.1% |
| Essa Pharma | Common Stock | 29668H104 | $5.5K | 1,696,969 | 3.8% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $4.7K | 2,483,949 | 3.3% |
| Editas Medicine(EDIT) | Common Stock | 28106W103 | $3.6K | 105,007 | 2.5% |
| Proteon Therapeutics | Common Stock | 74371L109 | $1.9K | 250,000 | 1.3% |
| Dicerna Pharmaceuticals(DRNAUSD) | Common Stock | 253031108 | $1.2K | 223,457 | 0.8% |
| CymaBay Therapeutics(CBAYUSD) | Common Stock | 23257D103 | $818 | 606,100 | 0.6% |